Form 4 for CSR CENTERSPACE
Accepted 2022-01-04 00:00:00 ET · period of report 2022-01-01 · accession 0000798359-22-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-04 | 2022-01-01 | CSR | Olson Anne | COO, Gen Counsel, Sec | M - OptEx | $0.00 | +539 | 10.7K | +5% | $0 |
| D | 2022-01-04 | 2022-01-01 | CSR | Olson Anne | COO, Gen Counsel, Sec | F - Tax | $110.90 | -311 | 10.3K | -3% | -$34.5K |
| DM | 2022-01-04 | 2022-01-01 | CSR | Olson Anne | COO, Gen Counsel, Sec | A - Grant | $96.52 | +8,646 | 1,121 | New | +$834.5K |
| D | 2022-01-04 | 2022-01-01 | CSR | Olson Anne | COO, Gen Counsel, Sec | M - OptEx | $0.00 | -539 | 1,080 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares of Beneficial Interest | 2022-01-01 | M | A | 539 | $0.00 | 10,653 | D | — | — | (F1) The number of shares includes 929 additional shares that were not previously reported due to administrative errors. The majority of these shares are time-vested RSUs that were appropriately reported as derivates on the reporting person's Forms 4 at the time of grant, but not recategorized as shares of common stock at the time of vesting. |
| 2 | Common | Common Shares of Beneficial Interest | 2022-01-01 | F | D | 311 | $110.90 | 10,342 | D | — | — | (F2) Represents shares withheld for payment of taxes in connection with the vesting of restricted stock. (F1) The number of shares includes 929 additional shares that were not previously reported due to administrative errors. The majority of these shares are time-vested RSUs that were appropriately reported as derivates on the reporting person's Forms 4 at the time of grant, but not recategorized as shares of common stock at the time of vesting. |
| 3 | Derivative | Stock Options (Right to Buy) | 2022-01-01 | A | A | 7,525 | $110.90 | 7,525 | D | $110.90 · — to 2032-01-01 | 7,525 Common Shares of Beneficial Interest | (F4) Represents the right to purchase 7,525 common shares of beneficial interest of the Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2023, 2024, 2025 and 2026. |
| 4 | Derivative | Restricted Stock Units | 2022-01-01 | A | A | 1,121 | $0.00 | 1,121 | D | $0.00 · — to — | 1,121 Common Shares of Beneficial Interest | (F3) Represents a contingent right to receive 1,121 common shares of beneficial interest of Centerspace vesting over three years, in one-third increments on each anniversary of the grant date: January 1, 2023, 2024 and 2025. |
| 5 | Derivative | Restricted Stock Units | 2022-01-01 | M | D | 539 | $0.00 | 1,080 | D | $0.00 · 2022-01-01 to 2022-01-01 | 539 Common Shares of Beneficial Interest |